跳转至内容
Merck
CN

244791

Sigma-Aldrich

酒石酸氧锑钾 水合物

≥99%

别名:

吐酒石

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C8H4K2O12Sb2 · xH2O
化学文摘社编号:
分子量:
613.83 (anhydrous basis)
MDL编号:
UNSPSC代码:
12352302
PubChem化学物质编号:
NACRES:
NA.22
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

方案

≥99%

表单

powder

旋光性

[α]20/D +141°, c = 2 in H2O

密度

2.6 g/mL at 25 °C (lit.)

SMILES字符串

O.[K+].[K+].O=C1O[Sb-]23OC1C4O[Sb-]5(OC(C(O2)C(=O)O3)C(=O)O5)OC4=O

InChI

1S/2C4H4O6.2K.H2O.2Sb/c2*5-1(3(7)8)2(6)4(9)10;;;;;/h2*1-2H,(H,7,8)(H,9,10);;;1H2;;/q2*-2;2*+1;;2*+3/p-4

InChI key

BBUFTTIHMIIQLI-UHFFFAOYSA-J

正在寻找类似产品? 访问 产品对比指南

应用

酒石酸氧锑钾水合物可作为 HPLC 法测定果汁中 Sb 类物质的标准。它还可以通过与三元 Keggin 型聚阴离子反应制备新的含 Sb(III)的聚阴离子。

象形图

Skull and crossbonesEnvironment

警示用语:

Danger

危险声明

危险分类

Acute Tox. 3 Oral - Acute Tox. 4 Inhalation - Aquatic Chronic 2

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Faceshields, Gloves

法规信息

危险化学品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

The antimony (iii)-bridged heteropolyanion sandwich dimers [SbIII3(A-a-XW9O34)2] 11-(X= Si IV, Ge IV) and C-shaped double-sandwich [SbIII6O2(PW6O26)(A-a-PW9O 34)2]15-.
Assran AS, et al.
Dalton Transactions, 41(33), 9914-9921 (2012)
Detection of antimony species in citrus juices and drinking water stored in PET containers.
Hansen HR and Pergantis SA.
Journal of Analytical Atomic Spectrometry, 21(8), 731-733 (2006)
Raquel Inocêncio da Luz et al.
Antimicrobial agents and chemotherapy, 53(12), 5197-5203 (2009-09-16)
Diagnostic material from patients with leishmaniasis is generally available as promastigotes, and proper testing for susceptibility to first-line drugs by the intracellular amastigote assay is frequently hampered by the poor infectivity of the promastigotes for the macrophage host cell. Several
T M-H Nguyen et al.
International journal of pharmaceutics, 482(1-2), 21-26 (2014-12-03)
Hyperphosphatemia is one of the main risk factors contributing to morbidity and mortality in patients with end stage renal disease. The demand for a new phosphate binder is continuously increasing since the number of patients suffering under hyperphosphatemia is growing.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持